// App-Quantinova.ai

P3-12-01 : Value-based approach to treatment of HER2-positive breast cancer: Examining the evidence

Researchers

Presenter

  • NA Nixon

Principal Investigators

  • M Hannouf

  • S Verma

Medical Centers

  • Ivey School of Business, Western University, London, ON, Canada

  • Tom Baker Cancer Center, Calgary, AB, Canada

Locations

  • Canada

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Breast cancer

Biomarkers

  • Human epidermal growth factor receptor 2

Drug/Treatment

  • Trastuzumab emtansine

  • Capecitabine

  • Trastuzumab

  • Pertuzumab

  • Lapatinib

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim

Copyright © 2026. QuantiNova All rights reserved